SELVAS Healthcare, Inc. (KOSDAQ:208370)

South Korea flag South Korea · Delayed Price · Currency is KRW
4,870.00
-65.00 (-1.32%)
Last updated: May 12, 2025
-1.52%
Market Cap 127.94B
Revenue (ttm) 31.70B
Net Income (ttm) 3.15B
Shares Out 25.72M
EPS (ttm) 122.00
PE Ratio 40.78
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 639,966
Average Volume 2,237,099
Open 4,990.00
Previous Close 4,935.00
Day's Range 4,850.00 - 5,100.00
52-Week Range 3,425.00 - 6,280.00
Beta -0.87
RSI 61.58
Earnings Date May 14, 2025

About SELVAS Healthcare

SELVAS Healthcare, Inc. operates as a medical device company in South Korea. The company provides body composition analyzers and automatic blood pressure monitors for hospitals. It also offers Braille Sense notetakers and other products for blind and visually impaired people under the HIMS brand name, as well as provides digital health products under the ACCUNIQ brand name. The company was formerly known as Jawon Medical Co., Ltd. and changed its name to SELVAS Healthcare, Inc. in September 2016. SELVAS Healthcare, Inc. was founded in 1999 and ... [Read more]

Industry Electromedical and Electrotherapeutic Apparatus
Founded 1999
Employees 118
Stock Exchange KOSDAQ
Ticker Symbol 208370
Full Company Profile

Financial Performance

In 2024, SELVAS Healthcare's revenue was 31.70 billion, an increase of 6.34% compared to the previous year's 29.81 billion. Earnings were 3.15 billion, a decrease of -39.03%.

Financial Statements

News

There is no news available yet.